Description

FOXO4-DRI is a synthetic peptide engineered to interfere with the interaction between FOXO4 and p53 within cellular senescence pathways. In controlled laboratory environments, it is studied for its role in disrupting protein–protein interactions associated with senescent cell survival mechanisms.

FOXO transcription factors are involved in cellular stress response, apoptosis regulation, and longevity-related signaling pathways. FOXO4-DRI (D-Retro-Inverso peptide design) is specifically structured to enhance stability in experimental systems while targeting FOXO4-mediated binding activity.

In preclinical and in vitro research models, FOXO4-DRI is commonly utilized to explore:

• Senescent cell pathway analysis

• p53 signaling interaction studies

• Apoptosis regulation mechanisms

• Cellular aging research frameworks

• Protein–protein interaction disruption modeling

Its targeted design makes it relevant in advanced research focused on aging biology, senescence signaling, and programmed cell response investigations.

Strictly intended for laboratory research use only. Not for human or veterinary use.